| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 6.13▲ | 6.06▲ | 6.00▲ | 5.89▲ | 6.71▼ |
| MA10 | 5.96▲ | 5.93▲ | 5.95▲ | 6.46▼ | 6.03▲ |
| MA20 | 5.91▲ | 5.93▲ | 5.91▲ | 6.77▼ | 6.26▼ |
| MA50 | 5.88▲ | 6.04▲ | 6.42▼ | 6.11▼ | 5.31▲ |
| MA100 | 6.14▲ | 6.79▼ | 6.88▼ | 6.45▼ | 3.57▲ |
| MA200 | 6.80▼ | 6.84▼ | 6.55▼ | 5.91▲ | 4.36▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.045▲ | 0.059▲ | 0.074▲ | -0.201▼ | -0.025▼ |
| RSI | 63.949▲ | 57.865▲ | 53.081▲ | 45.084▼ | 50.355▲ |
| STOCH | 93.786▲ | 66.510 | 56.074 | 8.354▼ | 71.905 |
| WILL %R | -16.495▲ | -16.495▲ | -16.495▲ | -82.993▼ | -57.344 |
| CCI | 101.669▲ | 133.190▲ | 104.658▲ | -81.095 | 4.848 |
|
Tuesday, May 12, 2026 10:17 PM
Verrica Pharmaceuticals Inc (VRCA) reports significant revenue growth and strategic milestones, despite facing financial and operational hurdles.
|
|
Monday, May 04, 2026 05:00 PM
WEST CHESTER, Pa., May 05, 2026 (GLOBE NEWSWIRE)-- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a therapeutics company developing and commercializing medications for the ...
|
|
Thursday, March 19, 2026 11:09 PM
VRCA Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Verrica Pharmaceuticals Inc. – VRCA Rosen Law Firm, a global investor rights ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 22/05/26 | 5.845 | 6.25 | 5.61 | 6.06 | 71,734 |
| 21/05/26 | 5.91 | 6.15 | 5.71 | 5.90 | 35,237 |
| 20/05/26 | 5.63 | 6.17 | 5.5726 | 6.02 | 31,084 |
| 19/05/26 | 5.87 | 5.99 | 5.56 | 5.59 | 49,346 |
| 18/05/26 | 6.27 | 6.4225 | 5.87 | 5.87 | 42,171 |
| 15/05/26 | 6.85 | 6.90 | 6.27 | 6.27 | 81,592 |
| 14/05/26 | 7.48 | 7.5899 | 6.8001 | 6.95 | 82,205 |
| 13/05/26 | 6.91 | 8.20 | 6.81 | 7.37 | 248,338 |
| 12/05/26 | 7.4233 | 7.4233 | 6.885 | 7.15 | 35,404 |
| 11/05/26 | 7.85 | 7.85 | 7.40 | 7.40 | 42,887 |
|
|
||||
|
|
||||
|
|